Solitary tumors of the peripheral nerves are uncommon and found to be benig
n in 90 p. 100 of the cases. They develop from the elements constituting th
e nerve and are generally schwannomas (80 p. 100). Other tumors are much mo
re exceptional and exhibit wide histological variability.
The diagnosis of a tumor of the peripheral nerve must be envisaged for all
cases with tumefaction or pain on the path of a nerve exacerbated at percus
sion. Magnetic resonance imaging is the preferred exploration technique, pa
rticularly useful in case of a deep tumor.
Preservation of nerve continuity is the underlying goal of the therapeutic
strategy, irrespective of the type of tumor. Extricable tumors are to be di
stinguished from inextricable tumors. Extricable tumors (schwannomas, intra
nervous lipomas) displace nerve fiber bundles without penetrating into the
bundle itself and can thus be resected without interrupting nerve continuit
y. Prognosis is excellent if no recurrence or degeneration occurs. In case
of persistent symptoms, a new exploration may be required to search for oth
er localized tumor(s) unperceived at the first procedure. Inextricable tumo
rs (solitary neurofibromas, hemangiomas of the Schwann sheath, neurofibroli
pomas) infiltrate the structural elements of the nerve fibers making comple
te excision impossible without altering the nerve fibers. Epineurotomy (ass
ociated with an interfascicular biopsy for pathology examination) allows de
compression and can often provide symptom relief although moderate paresthe
sia may persist. Patients must be informed of this possibility prior to sur
gery. Any recent and rapidly evolving modification in the clinical findings
is suggestive of recurrence and should be followed by revision exploration
. Malignant degeneration has not been observed in solitary tumors to our kn
owledge. Our own experience with 51 cases is generally in agreement with re
ports in the literature.